Pure Global

Anti Tissue Translutaminase IgA - India CDSCO Medical Device Registration

Anti Tissue Translutaminase IgA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000440_d39d85c22c5f28e598bc2f38dcc2bcbd_9f7515d66eddee3e3e612e638f5a21b4. The license holder is Immunoconcept India Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Anti Tissue Translutaminase IgA
UID: IMP/IVD/2021/000440_d39d85c22c5f28e598bc2f38dcc2bcbd_9f7515d66eddee3e3e612e638f5a21b4

Device Class

Class B

Approving Authority

CDSCO

Product Information

Anti Tissue Transglutaminase IgA is an indirect solid phase enzyme immunometric assay ##PLACEHOLDER_0## kit designed for the quantitative measurement of IgA class antibodies directed against tissue transglutaminase in human serum or plasma. The assay is intended for in vitro diagnostic use only as an aid in the diagnosis of celiac disease and dermatitis herpetiformis. Anti Tissue Transglutaminase IgA kit is intended for laboratory use only

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing